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Toward an etiological classification of developmental disorders normalities can occur as an isolated defect or as part of
of the kidney and upper urinary tract. There are a large number a recognized malformation syndrome [2, 3]. Renal agen-
of developmental disorders and syndromes that affect the kid- esis has been reported in 0.48 to 0.58 per 1000 live birthsney and upper urinary tract. These have generally been classi-
(unilateral agenesis at 1/200; bilateral agenesis 1/5,000fied according to morphological criteria established decades
ago. Although these classifications have been useful, they are to 10,000) and the incidence of obstructive uropathy has
incomplete, including some developmental disorders while ex- been reported in 1.27/1000 live births. Horseshoe kidneys
cluding others. Here, basic cellular and molecular biology stud- and cystic kidneys are diagnosed in 0.04 to 0.1 and 0.03ies of kidney and upper urinary tract development in both
to 0.05/ 1000 live births, respectively. Prevalence datarodents and humans are utilized to suggest the basis of a new
etiologic, if still tentative, classification scheme. This classifica- suggest that major kidney and urinary tract abnormali-
tion may help to identify candidate genes for human diseases ties occur in roughly 3 to 6 per 1000 live births. [2–4]. In
by correlating morphology with pathogenetic mechanisms. addition, major malformations, including those involving
the kidneys or lower urinary tract, are often lethal in
utero or shortly after birth. A review of 900 neonatalCongenital renal diseases are significant causes of mor-
autopsies from a single institution included 30 individualsbidity and mortality in children. The most common causes
of renal failure in pediatric patients are various develop- with renal agenesis/dysplasia, 18 with cystic kidneys, and
mental abnormalities. The North American Pediatric Re- 15 with lower urinary tract malformations [4]. Thus,
nal Transplant Cooperative Study (NAPRTCS) has gath- nearly 7% of neonatal deaths occurred in children with
ered data on children with chronic renal insufficiency, major congenital abnormalities of the kidneys and/or
those on dialysis, and those who have had renal trans- urinary tract.
plants. Among children in the NAPRTCS database diag- The inheritance pattern of some types of developmen-
nosed with chronic renal insufficiency, 23% had obstruc- tal diseases of the kidneys such as autosomal dominant
tive uropathy as the primary cause of their renal failure. polycystic kidney disease and autosomal recessive poly-
Renal aplasia, hypoplasia or dysplasia was reported in cystic kidney disease has been clearly determined. In other
18%, reflux nephropathy in 9% and cystic kidney disease cases, familial predisposition suggests that a defect has
in 4%. Thus, these four developmental renal abnormali- a genetic etiology, although the mechanism is unclear.
ties are responsible for 54% of children with chronic
For example, in a family with a child having renal agene-renal insufficiency. The same four diagnoses were found
sis, there is a 3.5% risk of recurrence in a subsequentin 34% of children receiving chronic dialysis and 40%
child if the parents have no renal disease and a 20% riskof children who had been transplanted [1].
of recurrence if one parent is also affected [4, 5].While good prevalence data are available in these se-
lected populations, the overall incidence of congenital re-
nal disease is difficult to estimate, since many cases are TRADITIONAL CLASSIFICATION SCHEMES
asymptomatic and, therefore, unrecognized. These ab- FOR URINARY TRACT MALFORMATIONS
IN HUMANS
Key words: morphology, pathogenetic mechanism, nephrogenesis, hu-
A variety of human congenital syndromes and isolatedman congenital syndromes, kidney malformation, renal pelvis, ureteric
bud. malformations affecting the kidney and the upper uri-
nary tract (defined as the urinary collecting system de-
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focused on cystic diseases, assigning such patients to four OVERVIEW OF NEPHROGENESIS
groups in the traditional Potter classification [reviewed Nephrogenesis may be divided into several different,
in 6]. Potter type I patients have autosomal recessive if interdependent, processes: (1) ureteric bud induction;
polycystic kidney disease. Patients with dysplastic and/or (2) collecting system development with branching tubu-
multicystic kidneys are classified as Potter Type II. Type logenesis; (3) metanephric mesenchyme conversion to
III cystic kidneys are seen in patients with autosomal epithelium followed by formation of epithelial tubules
dominant polycystic kidney disease and in patients with from this epithelium; and (4) glomerulogenesis. This sep-
other syndromes such as Meckel syndrome, tuberous aration is somewhat arbitrary since these processes over-
sclerosis and von Hippel-Lindau syndrome. Type IV cys- lap in time, and the interaction between the ureteric
tic kidneys are seen in association with obstruction. Al- bud and the mesenchyme is essential to nephrogenesis.
though they are not included in the Potter classification, Nevertheless, it is useful to consider the processes as
a variety of other cystic conditions such as medullary separate since they are regulated independently, at least
cystic disease, medullary sponge kidney and glomerulo- in part (see below). In addition, processes like angiogen-
cystic kidneys have been identified. esis/vasculogenesis and the further differentiation of the
Since the original work by Potter, several similar classi- kidney stroma occur simultaneously. Each step is com-
fication schemes have been developed [7, 8]. While clini- plex and requires a variety of genes (Table 1), which
cally useful, these schemes share a number of limitations: have been shown to play a role either by functional
(1) they focus on the morphology of cystic kidneys; (2) experiments in mice or by suggestive human phenotypes.
they exclude a variety of other developmental abnormal- In several cases, the assignment of a gene to a specific
ities of the kidney and upper urinary tract, such as renal process or subcategory appears likely, but not certain;
aplasia/agenesis and abnormalities of the ureters and glo- these genes are preceded in Table 1 by a question mark.
meruli (other than glomerulocystic disease); (3) primary Once specific genes have been assigned according to
versus secondary lesions are not distinguished clearly; their putative developmental role, diseases resulting
(4) more subtle structural disorders of kidney and uri- from defects in various genes can also be assigned
nary tract development and specific functional abnormal- (Table 2). In addition, morphological phenotypes, ex-
ities are not included; and (5) etiological and pathoge- pected to result from defects in specific processes, are
netic factors are disregarded. listed to provide a link between etiology and morphology
These classification schemes have been used clinically (Table 2). Inclusion of the categories “Before nephro-
for many years. However, in the context of current knowl- genesis” and “After nephrogenesis” emphasizes that the
edge, the Potter classification and its variants shed lim- spectrum of developmental abnormalities of the kidney
ited insight into the pathophysiology of the disease and and urinary tract includes lesions that precede the induc-
can create confusion in the interpretation of specific lesions. tion of the ureteric bud as well as those which become
For example, Branchio-Oto-Renal syndrome is caused by apparent after apparently normal nephrogenesis. The
a defect in a single gene (Eya-1) [9]. Patients with this etiological classification presented here is provisional. It
syndrome can have renal agenesis or vesicoureteral re- can be refined and/or corrected as the field advances.
flux (VUR), neither of which is part of the usual Potter This scheme has at least six advantages over the tradi-
classification. In other patients with this syndrome, the tional schemes devised by Potter and refined by others
developmental abnormality of the kidney may be renal [6–8]. First, the proposed classification scheme attempts
hypoplasia or dysplasia (Potter Type II) or ureteropelvic to correlate the morphological picture with the underly-
junction obstruction (Potter Type IV) [10]. Thus, pa- ing pathogenetic defect in development. Second, a vari-
tients with this disease, caused by a mutation in a single ety of developmental abnormalities such as renal agene-
gene, can fit into different Potter classifications, or may sis/aplasia and malformations of the ureter, which were
not be included at all, depending on the phenotype in the excluded from the Potter classification, are included.
individual case. A classification scheme based upon re- Third, defects in glomerulogenesis (such as congenital
cent information regarding nephrogenesis and the patho- nephrotic syndrome, Finnish type) and defects in the
genesis of urinary tract abnormalities, though perhaps maintenance of glomerular structure (such as Alport syn-
imperfect, would provide more insight into the nature drome) are included. Although in many instances, it is
of such conditions. By considering data from human and difficult to define the precise onset of the defect, to the
rodent studies, bearing both on normal and aberrant extent that these diseases result from abnormal renal
kidney and/or upper urinary tract development, it is pos- development, their exclusion from previous schemes is
sible to suggest a more etiological, if still tentative, clas- unwarranted. Fourth, hereditary defects resulting in dis-
sification scheme. This scheme classifies abnormalities ease during nephrogenesis are distinguished from defects
based upon the stage in nephrogenesis that is affected that are related to the maintenance of established renal
structures. Although the latter can manifest progressivein a given condition.
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Table 1. Genes and gene products implicated in kidney and upper urinary tract formation
Before nephrogenesis LIM1, PAX2
Nephrogenesis
Process 1: Ureteric bud induction WT1, Eya-1, GDNF, c-ret, ld, integrin 8, Hoxa11/d11, Foxc1/Mf1, Mf2, Foxc2/Mfh1, (Kal),
PAX2, laminin 5, Agtr2
Process 2: Collecting system development
Branching morphogenesis EMX2, BF2, RAR/2, Gata3, bmp4, bmp7, bcl-2, N-myc, FGF7, EGF-R, Pod1, FGF7, GDNF,
HGF, EGF, TGF-, heparan sulfate 2-sulfatotransferase, glypican-3, (?Kal), integrins 3,
6, and 4, laminin 5, MT1-MMP, MMP9 (gelatinase B), TIMP 1 and 2, ?Hoxa11/d11,
?Foxc1, ?Foxc-2, ?Mf2, (?HNF1)
Process 3: Formation of mesenchyme-derived tubules
Mesenchymal-epithelial transition Integrin 8, Wnt4, TIN-Ag, Pod1, GDNF, LIF, gp130, BMP7, BF2
Tubulogenesis Pod1
Process 4: Glomerulogenesis
Filtration barrier LMX1b, nephrin, CD2-AP, laminin 2
Mesangial WT1, PDGFB, PDGFB receptor
Vascular Laminin 5, ?Pod1
After nephrogenesis
Collecting system
Structural ADAMTS-1, Atg, ACE, AngII receptors types 1A and 1B, (PEX), (?VHL), AP-2, PKD1,
PKD2, Nek1, bcl-2, Rho-GD1, Tg737, TSC2, (?TSC1)
Functional/obstructive Atg, Agtr1A and 1B, ?ACE, ADAMTS-1
Mesenchyme-derived tubules Tensin, AP-2, bcl-2, PKD1, PKD2, Rho-GD1, Nek1, p58Kip2, COX-2, Tg737, (?VHL)
Glomerulus -actin-4, ColA3, (Col4A3-5), Rho-GD1, Nek1, COX-2
Extrinsic ?p63, ?Hoxa13
Table 2. Tentative developmental classification of disorders of kidney and upper urinary tract formation
Stage in renal development (apparent) Renal lesion Clinical syndromes (known or potential)
Nephrogenesis
Process 1: Ureteric bud induction Renal agenesis, duplications, Kallmann’s syndrome (Kal), Branchio-Oto-
?ectopy, ?hydro-ureter/nephrosis, Renal syndrome (EYA1), Renal-coloboma
?multicystic kidney syndrome (Pax2)
Process 2: Collecting system development
Branching morphogenesis Renal hypo/dysplasia, reduction in Hypoplasia, oligomeganephronia, Renal-
nephron number coloboma syndrome (Pax2), Branchio-
Oto-Renal syndrome (EYA1), MODY5
(HNF ), ?Kallmann’s syndrome
Process 3: Formation of mesenchyme-derived tubules
Mesenchymal-epithelial transition Renal hypo/dysplasia ?
Tubulogenesis Renal hypo/dysplasia ?
Process 4: Glomerulogenesis
Filtration barrier Normal renal architecture Congenital nephrosis, Finnish type (nephrin)
Mesangial Microscopic abnormalities Denys-Drash syndrome (WT1)




Structural Cyst formation ADPKD (PKD1, PKD2), nephronophthisis
(nephrocystin), Zellweger (PEX genes),
van Hippel-Lindau disease (VHL)
Functional/obstructive Hydroureter, hydronephrosis Nephronophthsis, ADPKD
Mesenchymal derived tubules Cyst formation Defective peristalsis of pelvis and ureter
Glomerulus Cysts, microscopic changes, fibrosis Alport syndrome (Col4A3-5), glomerulocystic
disease, FSGS (-actin-4)
renal disease that may not be obvious at birth, but they tools, which will increasingly complement gross morphol-
ogy and detailed microscopic examination of pathologicalcan nevertheless be due to molecular defects of renal
development. In a strict sense, certain hereditary disorders specimens. These techniques will aid in refining the classi-
fication (for example, by including terminal differentiationof tubular transport, although not discussed here at length,
also can be considered in this category. Fifth, the proposed defects). Sixth, the scheme suggests candidate genes to
test as causes of specific renal abnormalities.scheme is well adapted to the use of molecular diagnostic
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DEFECTS OCCURING AT DIFFERENT STAGES bud. C-ret is also up-regulated by GDNF [18]. Targeted
inactivation of either GDNF or c-ret leads to renal agen-OF NEPHROGENESIS
esis. Some heterozygous animals had unilateral renalBefore nephrogenesis
agenesis or hypoplasia, while others had apparently nor-
The first step of nephrogenesis is the induction of the mal renal development [19–22]. Mice carrying a sponta-
ureteric bud, which sprouts from the mesonephric duct neous limb-deformity (ld) mutation have either renal
at embryonic day 10.5 (E10.5) in mice. The transcription agenesis, usually unilateral, or normally developed kid-
factors, LIM1 and PAX2, are required for the correct neys (hypoplastic kidneys were observed less frequently).
formation of the mesonephric duct, from which the ure- It appears that ld gene products are important for ure-
teric bud sprouts. LIM1-deficient mice die around E10 in teric bud induction (process 1), because outgrowth was
most cases, so that the renal phenotype could not be delayed and the ureteric bud did not reach the metaneph-
thoroughly investigated, but both the mesonephros- ric mesenchyme [23]. Further investigation established
derived gonads and kidneys are missing. In addition, that the ld gene codes for four differentially spliced for-
LIM1 expression has been found early in the mesoneph- min genes, all of which are expressed in the mesonephric
ric duct [11, 12]. If PAX2 is functionally deleted, the duct as well as in the sprouting and branching ureteric
caudal part of the mesonephric duct does not form and bud [24]. Interestingly, mutation of formin IV appears
renal agenesis ensues [13]. Therefore, together these to affect only kidney development and does not to lead
genes help lay the ground for ureteric bud outgrowth. to the typical limb deformities [25].
They are also expressed in the growing ureteric bud itself Homozygous mutants for the integrin 8-subunit show
(process 2) and in the developing mesenchymally derived a phenotype similar to mice carrying the ld mutation. The
tubules (process 3), which argues for their persisting ureteric bud forms, but invasion into the metanephric
importance during metanephrogenesis [11, 14]. Human mesenchyme is delayed. Growth and branching of the
syndromes associated with abnormalities of the meso- ureteric bud and epithelialization of the metanephric
nephric duct have not been described, possibly because mesenchyme are defective, resulting in renal agenesis or
they may be fatal in utero. hypo/dysplasia. Thus, integrin 8 appears to play a role
Process 1: Ureteric bud induction. WT1, a zinc finger- in ureteric bud induction as well as in its further develop-
containing transcription factor, is expressed in the meta- ment (processes 1 and 2) [26]. Similarly, the homeo-
nephric mesenchyme surrounding the mesonephric duct, domain proteins Hoxa11 and d11 play an important role
and its presence is required for ureteric bud outgrowth to in ureteric bud development. Double homozygous mu-
occur. In homozygous null-mutants for WT1, no kidneys tants, but not the respective single mutants, have hypo-
form, although the mesonephric ducts are present [15]. plastic or absent kidneys. In these mutants, glomeruli
WT1 continues to be expressed later in nephrogenesis and nephrons are sparse, but normally developed, sug-
and is needed for further renal development. When a gesting a primary role for Hoxa11 and d11 in ureteric bud
mutated WT1 gene was introduced, a truncated protein induction and branching morphogenesis (processes 1
formed. These animals developed kidneys, but mesangial and 2) [27].
sclerosis developed, leading to a phenotype similar to In addition to the genes described above, which appear
the Denys-Drash syndrome in humans. One animal de- to be directly involved in ureteric bud outgrowth, modu-
veloped a Wilms tumor [16]. lators of its induction and branching have been identified.
The expression of the transcription factor Eya-1 in the Three forkhead/winged transcription factors, Foxc1/Mf1,
metanephric mesenchyme also is required for ureteric Mf2, and Foxc2/Mfh1 are expressed in the mesenchyme
bud outgrowth. In mice with homozygous null-mutations adjacent to the mesonephric duct and the branching ure-
for Eya-1, renal induction does not occur and kidneys teric bud. Homozygous mutants of Foxc1/Mf1 exhibit
fail to form. In heterozygous mice, a spectrum of urinary renal duplication, hydroureters and hydronephrosis in
tract malformations similar to the Branchio-Oto-Renal more than 85% of animals in one strain while these ab-
syndrome in humans is found [17]. Interestingly, WT1 normalities were uncommon in a second strain with a
expression was present in Eya-1 deficient homozygotes, similar mutation. Identical malformations were seen in
whereas glial cell line-derived neurotrophic factor homozygous null-mutants of Mf2, but in only 20 to 40%
(GDNF)-expression was not, suggesting that there is a of the mice. In these animals, the developing kidneys are
signaling cascade leading to the mesenchymal signal for not hypoplastic, but hypoplasia was seen in compound
ureteric bud outgrowth. It appears that WT1 acts early heterozygotes of Foxc1/Mf1 and Foxc2/Mfh1 [28, 29].
in the cascade, followed by Eya-1 and, then, GDNF. It appears likely that various human abnormalities in-
Glial cell line-derived neurotrophic factor (GDNF) cluding Kallmann’s syndrome, Branchio-Oto-Renal syn-
appears to act as a soluble growth factor, secreted from drome and Renal-coloboma syndrome are caused by
the metanephric mesenchyme and bound by its receptor abnormalities in the induction of the ureteric bud since
there are a variety of developmental renal abnormalitiesc-ret on the tips of the branching and elongating ureteric
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seen in patients with these syndromes. This variety is eration/apoptosis is a major function of growth factors;
these processes appear essential for normal branching,similar to that described above in mice with defects in
ureteric bud induction. as experiments with null-mutants for bcl-2 and n-myc
have shown [37–39]. Appropriate spatiotemporal regula-Process 2: Ureteric bud branching morphogenesis.
Branching morphogenesis of the ureteric bud is regu- tion of apoptosis versus proliferation may be important
in the cavitation of ureteric bud-derived structures, andlated by transcription factors, growth factors and matrix
elements. EMX2, a transcription factor expressed in the thus dysregulation of these processes may result not only
in renal hypo/dysplasia but also structural lesions of theureteric bud, is required for the first branching event to
occur [30]. The Winged-Helix transcription factor, BF-2, urinary tract.
Both fibroblast growth factor-7 (FGF7) and epithelialis only expressed by the stromal cells within the devel-
oping kidney [31]. Disruption of the BF-2 gene in mice growth factor receptor (EGF-R) also are implicated in
ureteric tree development, but the interruption of thesehas no effect on ureteric bud induction, but both ureteric
bud branching morphogenesis (process 2) and the mes- pathways causes less severe phenotypes. Homozygous
mutant mice for FGF7 develop smaller collecting systemsenchymal-epithelial transition (process 3) are abnormal.
Kidneys from null-mutants develop normally until E12.5, with somewhat fewer, but normal, nephrons [40]; how-
ever, other FGFs may be equally if not more importantbut, thereafter, show a significant decrease in ureteric bud
branching and delayed epithelialization of the condensed in branching morphogenesis based on in vitro studies of
the isolated ureteric bud [41]. One mouse strain lackingmesenchyme [31]. These findings are much more severe
than those found in animals lacking Mf2, even though the EGF-receptor shows a normally branched, but cys-
tically deformed collecting system (in two other strains,the two genes encode DNA binding domains which differ
by only one amino acid [29]. the mice die early in embryogenesis) [42]. GDNF is not
only necessary for early bud outgrowth, but also forThe retinoic acid receptors  (RAR) and 2 (RAR2)
also are expressed in stromal cells in the kidney. Their continued branching, at least in vitro [43]. Despite ex-
pression of hepatocyte growth factor (HGF) and its re-combined targeted disruption, but not the respective sin-
gle deletions, severely disturbs branching morphogenesis ceptor c-met in the metanephric mesenchyme and the
ureteric bud, respectively, kidneys of mice deficient forof the ureteric bud, but not its induction [32]. Thus, the
stromal genes known to date (RAR, RAR2 and BF2) either of them appear completely normal until embry-
onic days 14 to 16, when the animals die in utero [44, 45].seem to regulate the branching but not the induction of
the ureteric bud. However, in organ culture HGF appears to be necessary
for kidney development [46–48]. In cell culture models,A similar renal defect is found in mice lacking Gata3,
which (in the developing kidney) is exclusively expressed HGF supports the formation of structures thought to
model the developing ureteric bud. EGF receptor ligandsby the ureteric bud. It appears to be required for the
differentiation of the metanephric mesenchyme and, per- [EGF, transforming growth factor- (TGF-)] had a sim-
ilar effect [49, 50]. However, it appears that other, ashaps subsequently, for ureteric bud branching but not
ureteric bud induction [33]. yet unidentified, growth factors may be more important
regulators of ureteric bud branching. In isolated uretericThe heterozygous mutation of the growth factor, bone
morphogenetic protein 4 (bmp4), results in a variety of bud culture, soluble heparin-binding activities produced
by a metanephric cell line is necessary for extensiveabnormalities of the kidneys and urinary tract including
renal hypoplasia/dysplasia, ureterovesical junction ob- branching of the ureteric bud [43]. One of these activities
has recently been identified as pleiotropin [50].struction causing hydronephrosis and duplex kidneys
with bifid ureters. Renal agenesis has not been described, Thus, many growth factors have potentially overlap-
ping effects on ureteric branching. In mutant animals,suggesting that this gene functions in branching (process 2)
and not in the induction of the ureteric bud (process 1). phenotypic changes only occur with permissive genetic
backgrounds or in multiple knockouts. Since organ de-There can be considerable phenotypic variability in two
kidneys of the same animal and among animals. Bmp4 velopment occurs during a relatively brief period that is
obviously critical for the viability of the fetus, a highappears to have two effects. It promotes the growth and
elongation of the ureteric bud. In addition, it inhibits the level of redundancy between multiple factors in critical
developmental pathways makes teleological sense.ectopic budding of the Wolffian duct, preventing duplica-
tion of the ureter [34]. Growth factors in addition to Matrix elements also play an essential role in branch-
ing morphogenesis. Normal production of heparan sul-bmp4 are needed for the continuation of the branching
process. Bmp7 is expressed by the ureteric bud and, in its fate proteoglycans is important for initial branching of
the ureteric bud. In mice with homozygous null-muta-absence, the metanephric mesenchyme condenses poorly
around the tips and undergoes apoptosis, which effec- tions for the heparan sulfate 2-sulfotransferase, the ure-
teric bud forms and invades the metanephric mesen-tively stops nephrogenesis and results in a severe renal
phenotype [35, 36]. Regulation of ureteric bud cell prolif- chyme, but fails to undergo its initial branching step [51].
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Other extracellular matrix related molecules appear to ties appear to result from defects in branching morpho-
genesis (Table 2).be important for normal nephrogenesis. Experiments
Process 3: Mesenchymal-epithelial transition. Some ofutilizing embryonic ureteric bud-derived cells suggest
the gene products important in process 2 of nephrogen-that the interaction of hyaluronan with CD44 may sup-
esis (branching morphogenesis of the ureteric bud) alsoport survival and branching of the ureteric bud during
may affect the mesenchymal-epithelial transition, whichearly metanephric development [52].
occurs at approximately the same time. For example,In contrast, mutation of glypican 3, a cell-surface he-
integrin 8 is expressed only in the mesenchyme, andparan sulfate proteoglycan causes the Simpson-Golabi-
in 8-deficient mice both mesenchymal epithelializationBehmel syndrome with renal dysplasia in humans. This
and ureteric bud branching do not occur [26]. One factor,abnormality leads to increased initial branching of the
wnt4, appears to be important for the development ofureteric bud, cystic changes and disorganization of med-
the mesenchyme but not for branching morphogenesis.ullary tubules in later stages in mice. The reason for
Ureteric buds from wnt4-deficient mice branch normally,those changes appeared to be increased proliferation in
and the metanephric mesenchyme condenses normallythe ureteric bud-derived epithelium [53].
around the ureteric bud tips, but never enters mesenchy-Anosmin-1, the gene product of the Kal gene, which
mal-epithelial transition [64]. In addition, inhibition ofis defective in Kallmann’s syndrome (anosmia, hypogo-
tubulointerstitial nephritis antigen (TIN-Ag) with eithernadotropic hypogonadism, frequent renal agenesis), is
an antisense oligodeoxynucleotide or with anti-TIN-Aglocalized to the basal membrane of the mesonephric duct
antibody dramatically decreases the formation of mesen-and ureteric bud. Its absence leads to renal agenesis
chymally derived tubules, but not ureteric bud branchingin some individuals, but not all, suggesting that other
or the development of glomeruli [65]. This suggests thatmolecules can substitute for anosmin-1, at least in part
ureteric bud branching is dependent on signals from the[54].
condensed mesenchyme and does not require mesenchy-In addition to integrin 8, the integrin subchain 3 ap-
mally-derived tubules. If this is the case process 2 (ure-pears to be required for normal kidney development.
teric bud branching) and process 3 (mesenchymal-epi-Mice deficient in3 develop fewer nephrons than normal, thelial transition) can be conceptionalized as separate,but they are morphologically normal. Both genetic and
albeit interrelated parts of renal development. This no-in vitro data support a key role for integrins in ureteric
tion is consistent with in vitro data demonstrating thatbud branching. Likewise, a pathway involving the integ-
isolated ureteric bud branching can occur in the absencerin subchains that bind laminin 5 might contribute to
of contact with the mesenchyme [43].ureteric bud branching [55].
On the other hand, similar to BF2, the helix-loop-helix
During nephrogenesis, the extracellular matrix around
transcription factor Pod1 affects both nephron formation
the developing ureteric bud is extensively remodeled. and ureteric bud branching and is thought to act at least
In vitro studies have demonstrated the involvement of partly downstream of Pax2, BF2 and Wnt4, which are nor-
metalloproteinases (MMPs) or inhibitors in kidney de- mally expressed in Pod1 null-mutants [66]. Until more
velopment, including MT1-MMP, MMP9 (gelatinase B), detailed molecular knowledge of the pathways involved
tissue inhibitors of metalloproteinase-1 (TIMP-1), and is available, theories about the precise interaction remain
TIMP-2 [56–58]. speculative.
Any abnormality in branching morphogenesis, in prin- Because many targeted deletions in mice affect the kid-
ciple, could result in the formation of fewer nephrons ney at the level of ureteric bud outgrowth or early branch-
than are normally found. However, it is important to ing and therefore hinder further development, less is
emphasize that equation of nephron number directly known about specific factors guiding the later steps in
with uretric bud branching may be oversimplifying mat- the intact fetus. Recently, in vitro assays aimed at repro-
ters; “independent” defects in metanephric mesenchyme ducing the processes of ureteric bud branching and mes-
conversion and differentiation as well as glomerular and enchymal-epithelial transition have been developed us-
stromal development may also result in altered nephron ing both embryonic tissues and cell lines [43, 67, 68].
number. In the absence of any obvious renal disease, Two models for branching morphogenesis of the ureteric
nephron number may vary significantly in the general bud have been studied extensively. The first is an embry-
population, and there may also be ethnic differences in onic cell line, derived from the ureteric bud at E11.5.
average nephron number. Decreases in nephron number The second, which has already been alluded to, utilizes
have been postulated to be a cause of hypertension, explanted isolated ureteric buds from rats, cultured in a
proteinuria and focal and segmental glomerulosclerosis. Matrigel/collagen matrix and stimulated with condi-
There is some support for this theory, both in humans tioned medium from an embryonic metanephric mesen-
and in experimental animals [60–63]. chyme cell line in the presence of GDNF [43, 67]. One
potential morphogeneric factor in this conditioned me-A variety of human renal developmental abnormali-
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dium has recently been identified as pleiotropin [50]. and its targeted mutation affects ureteric bud branch-
ing and the mesenchymal-epithelial transition [66, 81].Using isolated mesenchymal explants, leukemia inhibi-
tory factor (LIF), secreted from a ureteric bud cell-line, The gene ACTN4 encodes for -actinin 4. This protein
is highly expressed in the glomerular podocyte, predomi-has been isolated as a potential key factor that helps
trigger the mesenchymal-epithelial conversion, and the nantly in the foot processes. The gene has been shown to
be abnormal in three families with autosomal dominanttargeted mutation of its receptor gp130 leads to reduced
nephron numbers [68]. focal segmental glomerulosclerosis (FSGS). The mutant
-actinin 4 binds F-actin more strongly than the wildBoth the collecting duct and the mesenchyme-derived
tubules terminally differentiate to assume specialized type. This appears to be related to the pathogenesis of
the FSGS [82].functions. There is both structural and functional seg-
mentation along the nephron, which is reflected in both
After nephrogenesiscell function and gene expression. For example, genes
involved in proximal tubular transport of organic anions Some malformations, for example, hydronephrosis from
ureteropelvic junction obstruction (URTO), do not nec-and cations occur early (mouse E14 to E16), while those
involved in sodium-glucose transport are expressed later essarily result from primary dysfunctional ureteric bud
development. Homozygous mutation of ADAMTS-1, a(mouse E17 to E19). These transporters could play a role
in organ development [69, 70]. Targeted null-mutation metalloproteinase-disintegrin, leads to classical bilateral
UPJO as a result of increased fibrosis in the ureter wall.of the transcription factor, hepatocyte nuclear factor-
(HNF-), leads to severe proximal tubular dysfunction Hypoplasia or dysplasia is not seen in these animals. The
structural development of the urinary tract is apparently(Fanconi syndrome) in one mouse strain, but not in an-
other, again stressing the influence of modifying genes normal until birth. Hydronephrosis develops over several
weeks after birth in mice carrying the mutations [83]. A[71, 72]. The broad array of renal transport defects, which
results from mutations in transporter and channel genes somewhat similar phenotype appears in the urinary
tracts of mice in which the angiotensin 2 pathway isand leads to diseases like Bartter syndrome and nephro-
genic diabetes insipidus, can, in a strict sense, be regarded interrupted by targeted mutation of angiotensinogen,
angiotensin-converting enzyme (ACE) or by the com-as developmental renal disorders.
Process 4: Glomerulogenesis. Glomerulogenesis in- bined lack of angiotensin receptor types 1a and 1b
[84–86]. Interstitial fibrosis develops and the renal papillavolves the coordination of epithelial, vascular and mes-
angial development. The lack of the LMX1b gene prod- atrophies, probably due to dysfunctional ureteral peri-
stalsis during and after renal development [87]. There-uct leads to morphological and functional abnormality
of the glomerular basement membrane. This abnormality fore, there appears to be a group of molecular defects,
which leads to urinary flow disturbance and, as a conse-and the remainder of the features of these mice are very
similar to those seen in human Nail-Patella syndrome quence, alters renal structure. These genes could act as
modifiers to help explain part of the phenotypic variabil-[73, 74]. Newborns with mutations in nephrin, which is
part of the slit diaphragm and therefore a component of ity seen in congenital upper urinary tract malformations
or in knockout mice that have a wide variety of renalthe barrier between the glomerular vessels and the Bow-
man space, suffer from congenital nephrosis of the Finn- abnormalities. Appropriately regulated apoptosis may
be important in the formation and preservation of theish type [75]. Similar phenotypes are found in mice with
homozygous null-mutations for CD2-associated protein ureter, and defects in these processes could also lead to
structural lesions.(CD2-AP), which interacts with nephrin in the formation
of the glomerular slit membrane [76], and laminin 2, Once the kidney is correctly formed, its structures must
be preserved, and it must withstand mechanical and func-which appears to be required for the functional integrity
of the glomerular basement membrane [77]. tional stress. If genetic defects render kidneys vulnera-
ble, deterioration of renal function may occur. Much hasAs mentioned earlier, a mutation in WT1, leading
to the formation of a truncated protein, allows kidney been learned about genetic defects from the study of pa-
tients with such diseases and an increasing number offormation, but leads to mesangial sclerosis with the ani-
mals developing a phenotype similar to the Denys-Drash mice with targeted mutations mimic the process. Over
time, patients with Zellweger syndrome or von Hippel-syndrome in humans [16]. Platelet-derived growth factor
B (PDGFB) and its receptor PDGFBR also are required Lindau disease develop renal cysts; the responsible gene
defects for these diseases (PEX and VHL, respectively)for the formation of mesangial cells [78, 79].
Targeted deletion of the laminin 5 chain, a component have been identified [88, 89]. Targeted mutations in ten-
sin, AP-2, bcl-2, PKD1, PKD2, Rho-GDI, Nek1 andof the glomerular basement membrane, leads to glomer-
ular malformations with failure of vascularization and, in p57Kip2 and a mutation in TgN737 cause changes reminis-
cent of polycystic kidney disease or medullary cystic dis-some cases, renal agenesis [80]. Pod 1 is strongly expressed
by the visceral epithelial glomerular cells (podocytes) ease in mice [17, 27, 39, 90-96]. Apart from PKD1 and
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PKD2, mutations of these genes have not been described rodent kidney development have already begun to be
in humans. They represent interesting candidate genes analyzed using cDNA arrays [100]. The proposed classi-
for genetically unassigned diseases that lead to cyst for- fication scheme provides a model that will allow a deeper
mation. Although such defects lead to abnormal kidneys understanding of the relationship between abnormal
in mice, some may not be causes of aberrant kidney genes, as they are identified, and the pathogenesis of
development in a strict sense, because until the comple- abnormalities of the kidneys and urinary tract.
tion of nephrogenesis the kidneys are often structurally To further this process, it will be desirable to develop a
or functionally unaffected. registry of patients with various forms of developmental
Similarly, genetic abnormalities can lead to glomerular abnormalities of the kidneys and urinary tract. With this
disease after apparently normal renal development. Nev- information, it will be possible to combine molecular
ertheless, because of the possibility that subtle functional biology, on one hand, and classical epidemiologic meth-
and/or structural defects may be present at birth, it is im- ods, on the other, to continue increasing our knowledge
portant to consider them here. Alport syndrome is caused regarding the pathogenesis of these disorders.
by defects in collagen IV synthesis and leads to progres-
Reprint requests to Sanjay K. Nigam, M.D., Division of Nephrologysive renal failure in mice and humans [97, 98]. Progressive
and Hypertension, Departments of Pediatrics and Medicine, Universitydeterioration of renal function can result from focal seg- of California, San Diego, 9500 Gilman Drive (0693), La Jolla, California
mental glomerulosclerosis (FSGS), one form of which is 92093-0693, USA.
E-mail: snigam@ucsd.educaused by defects of -actinin-4 [82]. In addition to the
cystic changes noted earlier, mice deficient in Rho GDI
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